Trump Medicare Drug Rule Saves Less Than Proposed Amid Bipartisan Pushback
The administration's final rule applies to only four companies while lawmakers warn it hinders patient access to new cancer treatments.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The odds
Each tick is a source publishing on this story · 1 more published before price tracking began
Price data
| Time | Chance of yes |
|---|---|
| now | 21% |
| 3 Oct, 10:17 UTC | 21% |
| 30 Sept, 23:32 UTC | 28% |
| 29 Sept, 23:20 UTC | 29% |
Replay the odds, article by article
Step through each article in the order it published and watch Yes respond.
The story so far
3 publishers have covered this in 4 articles since 28 Sept 2026. Fox News Politics published first, on 28 September at 23:46 UTC; STAT followed 47h 29m later. The most recent article, from The Hill, appeared on 1 October at 23:51 UTC.
Outlets reporting it: The Hill (major outlet), Fox News Politics, STAT.
One prediction market prices this story:
- Yes — the market puts it at 21%, with $23 traded in the last 24 hours, closing 3 Nov 2026. The market resolves to Yes if Donald Trump signs an executive action imposing a tariff of at least 100% on imported generic pharmaceutical drugs before November 3, 2026. Otherwise, it resolves to No. Readers often mistake the linked news story about Medicare drug rules for the required tariff action.
Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.
How it unfolded
Every source in the order it published, with the odds on Yes at that moment. A dash means the source published before we started tracking prices.
- Fox News PoliticsTrump CMS faces bipartisan pushback over Medicare proposal tied to Biden-era drug pricing law—
- STATTrump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal29%
- STATSTAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more28%▼1 points since the previous source
- The HillMedicare de-fangs new drug pricing model28%
- Current odds21%
Sources
Every article we clustered into this story. Headlines link to the publisher.
- Medicare de-fangs new drug pricing model The Hill ·
- STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more STAT
- Trump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal STAT
- Trump CMS faces bipartisan pushback over Medicare proposal tied to Biden-era drug pricing law Fox News Politics
Related prediction markets
Linked by software because they are about the same subject. Most ask a different question from the one this story reports, so read each market's own question. How often the link is right
- Kalshi Yes 21% −7
Does the market have this right?
Wrong market?
Have your say
Email me when the odds move
In this story
- Donald Trump
- CMS